Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2014 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Continuous subcutaneous insulin infusion (CSII) of insulin aspart versus multiple daily injection of insulin aspart/insulin glargine in type 1 diabetic patients previously treated with CSII.
Hirsch IB, Bode BW, Garg S, Lane WS, Sussman A, Hu P, Santiago OM, Kolaczynski JW; Insulin Aspart CSII/MDI Comparison Study Group. Hirsch IB, et al. Diabetes Care. 2005 Mar;28(3):533-8. doi: 10.2337/diacare.28.3.533. Diabetes Care. 2005. PMID: 15735183 Clinical Trial.
OBJECTIVE: Multiple daily injection (MDI) therapy of bolus insulin aspart and basal insulin glargine was compared with continuous subcutaneous insulin infusion (CSII) with aspart in type 1 diabetic patients previously treated with …
OBJECTIVE: Multiple daily injection (MDI) therapy of bolus insulin aspart and basal insulin glargine was compare …
Comparison of continuous subcutaneous insulin infusion and insulin glargine-based multiple daily insulin aspart injections with preferential adjustment of basal insulin in patients with type 2 diabetes.
Gao GQ, Heng XY, Wang YL, Li WX, Dong QY, Liang CG, DU WH, Liu XM. Gao GQ, et al. Exp Ther Med. 2014 Oct;8(4):1191-1196. doi: 10.3892/etm.2014.1866. Epub 2014 Jul 29. Exp Ther Med. 2014. PMID: 25187822 Free PMC article.
The purpose of this study was to evaluate and compare multiple daily injection (MDI) therapy of bolus insulin aspart and basal insulin glargine with continuous subcutaneous insulin infusion (CSII) with aspart in patients wit …
The purpose of this study was to evaluate and compare multiple daily injection (MDI) therapy of bolus insulin aspart …
Basal insulin supplementation in Type 1 diabetic children: a long-term comparative observational study between continuous subcutaneous insulin infusion and glargine insulin.
Schiaffini R, Patera PI, Bizzarri C, Ciampalini P, Cappa M. Schiaffini R, et al. J Endocrinol Invest. 2007 Jul-Aug;30(7):572-7. doi: 10.1007/BF03346351. J Endocrinol Invest. 2007. PMID: 17848840
As part of routine clinical care, the patients consecutively changed their previous insulin scheme (isophane insulin at bedtime and human regular insulin at meals) and were randomly selected in order to receive either multiple daily injections (MDI) tr …
As part of routine clinical care, the patients consecutively changed their previous insulin scheme (isophane insulin at bedtim …